Clinical results after biliary drainage by endoscopic retrograde cholangiopancreatography for analysis of metastatic cancer survival and prognostic factors

Yuan, Peng; Zhang, Lei; Li, Shijie; Li, Xun; Wu, Qi

doi:10.1007/s00464-020-08121-2

Cited by 3 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is only one study on prognostic factors after ERCP stenting for biliary drainage in metastatic cancers of various origins[ 56 ]. Colorectal cancer was the most common primary (25%), and there was only one case of renal cell carcinoma.…”

Section: Treatmentmentioning

confidence: 99%

Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer

Okamoto¹

2022

WJG

View full text Add to dashboard Cite

Malignant biliary obstruction generally results from primary malignancies of the pancreatic head, bile duct, gallbladder, liver, and ampulla of Vater. Metastatic lesions from other primaries to these organs or nearby lymph nodes are rarer causes of biliary obstruction. The most common primaries include renal cancer, lung cancer, gastric cancer, colorectal cancer, breast cancer, lymphoma, and melanoma. They may be difficult to differentiate from primary hepato-pancreato-biliary cancer based on imaging studies, or even on biopsy. There is also no consensus on the optimal method of treatment, including the feasibility and effectiveness of endoscopic intervention or surgery. A thorough review of the literature on pancreato-biliary metastases and malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer is presented. The diagnostic modality and clinical characteristics may differ significantly depending on the type of primary cancer. Different primaries also cause malignant biliary obstruction in different ways, including direct invasion, pancreatic or biliary metastasis, hilar lymph node metastasis, liver metastasis, and peritoneal carcinomatosis. Metastasectomy may hold promise for some types of pancreato-biliary metastases. This review aims to elucidate the current knowledge in this area, which has received sparse attention in the past. The aging population, advances in diagnostic imaging, and improved treatment options may lead to an increase in these rare occurrences going forward.

show abstract

Section: Treatmentmentioning

confidence: 99%

Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer

Okamoto¹

2022

WJG

View full text Add to dashboard Cite

show abstract

“…Achieving effective and durable biliary decompression is the mainstay of treatment for MBO, including endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic biliary drainage (PTBD), and endoscopic ultrasound-guided biliary drainage (EUS-BD). Clinically successful drainage with a decrease in serum bilirubin has significantly impacted patient prognosis and survival [ 2 , 9 ]. PTBD is a standard treatment method for patients with unsuccessful or infeasible ERCP.…”

Section: Introductionmentioning

confidence: 99%

Correlation between functional drainage and survival in malignant biliary obstruction after percutaneous biliary drainage

Yang,

Qin,

Tang

et al. 2024

Heliyon

View full text Add to dashboard Cite

“…Early diagnostics play a key role in managing the complete anatomy of hepatobiliary pancreatic disease, tumor marker, USG, MSCT, MRCP, ERCP, and laparoscopic coming as diagnostic techniques and modalities with various capabilities and availability. For late-detected diseases disorders, pre-operative drainage is more helpful in improving operative treatment outcomes and prolonging survival [10], [11], [12]. The previous research publications on total bilirubin from different times and sample backgrounds, show the ability and variation of threshold value as a predictors of malignant obstructive jaundice [13], [14], [15].…”

Section: Introductionmentioning

confidence: 99%

Advantages of Total Bilirubin for Predicting Malignant Obstructive Jaundice, A Combination of the Pandemic Era and Limited Resources Settings

Suchitra

Rivai

Mitra

et al. 2023

Open Access Maced J Med Sci

View full text Add to dashboard Cite

BACKGROUND: Hepatopancreatobiliary (HPB) cancer incidence and mortality are increasing worldwide. An initial diagnostic predictor is needed for recommending further diagnostic modalities, referral, and curative or palliative decisions. There were no studies conducted in area with limited accessibility setting of the COVID-19 pandemic, coupled with limited human resources and facilities. AIM: We aimed to investigate the advantages of total bilirubin for predicting malignant obstructive jaundice, a combination of the pandemic era and limited resources settings. METHODS: Data from all cholestasis jaundice patients at M. Djamil Hospital in Pandemic COVID-19 period from July 2020 to May 2022 were retrospectively collected. The data included demographics, bilirubin fraction results, and final diagnosis. Bivariate analysis for obtain demographic risk factor, and Receiver Operating Characteristics (ROC) analysis for getting bilirubin value. RESULTS: Of a total 132 patients included, 35.6% were malignant obstructive jaundice, and Pancreatic adeno ca was the most malignant etiology (34.4%). Bivariate analysis showed a significant correlation between age and malignant etiology (p = 0,024). Direct and total Bilirubin reach the same level of Area Under Curve (AUC). Total bilirubin at the cutoff point level of 10.7 mg/dl had the most optimal results on all elements of ROC output, AUC 0.88, sensitivity 76.6%, specificity 90.1%, +LR 8.14, and -LR 0.26. CONCLUSION: The bilirubin fraction is a good initial indicator for differentiating benign and malignant etiology (AUC 0.8–0.9) in pandemic era and resource-limited areas to improve diagnostic effectiveness and reduce referral duration.

show abstract

Clinical results after biliary drainage by endoscopic retrograde cholangiopancreatography for analysis of metastatic cancer survival and prognostic factors

Cited by 3 publications

References 23 publications

Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer

Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer

Correlation between functional drainage and survival in malignant biliary obstruction after percutaneous biliary drainage

Advantages of Total Bilirubin for Predicting Malignant Obstructive Jaundice, A Combination of the Pandemic Era and Limited Resources Settings

Contact Info

Product

Resources

About